chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Felt palpitations as fast heart beat and some shortness of breath about 10 minutes after receiving the vaccine.  Symptoms lasted about 20 minutes gradually resolving.
Staff received incoming call at clinic. Patient states s/p J&J vaccination 4/12/21 at EVC. C/O continuous HA that is worsening even with Tylenol 500 mg PO PRN. HA is worst at 8/10. C/O mild intermittent lightheadedness. C/O anxiety. Denies hx of HA, dizziness, anxiety. No other complaint. Advised to go to the nearest ED.
Occasional very sharp pain in the center of chest below the breastbone (has occurred approximately 7-8 times since with the latest occurring in the past week (sometimes after sitting at work desk for hours, other times after physical training), frequent palpitations (daily particularly noticed at night when attempting to sleep), high blood pressure (daily), pressure in the upper chest and throat (1-2 times weekly), shortness of breath and lack of energy when conducting cardiovascular exercise.
4 days later minor blood clot in my finger (not sure it is drug related); Bruise at site of injection; This is a spontaneous report from a non-contactable consumer (patient). A 35-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 09Apr2021 (Batch/Lot number was not reported) as SINGLE DOSE for COVID-19 immunization. Medical history and concomitant medications were not reported.  On 13Apr2021, the patient had bruise at site of injection and 4 days later (17Apr2021) minor blood clot in her finger was noted (not sure it was drug related). The patient had no COVID-19 prior vaccination and not tested post vaccination. The patient requires doctor or other healthcare professional office/clinic visit for the events and unknown if treatment was received. The patient had not yet recovered from the events.   No follow up attempts are possible. information about lot/batch number cannot be obtained
Facial swelling, hives over trunk (severe) and arms and legs. Initially had cough immediately after - pt came back to our office at 1220 pm.
Employee received MMR on 9/13/2019 r/t nonimmunity to Rubella. Employee complain of rash that started on face, knots to back of head, itching, "feeling funny in the right facial area" on 9/25/2019, employee to see clinic provider on 9/26/2019 with rash to face, neck, trunk, BUE's, BLE's to mid-thigh area, large amount of redness to both eyes with watering, itching, soreness to bilateral lymph nodes, dizziness.
arm began to hurt; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LIMB DISCOMFORT (non-serious), outcome "recovered" (2021), described as "arm began to hurt". Therapeutic measures were taken as a result of limb discomfort.  Additional information included: she applied ice and arnica on the arm and pain went away.  No follow-up attempts are possible. No further information is expected.
Pt developed headache on Sunday 7pm and developed mild fever on Monday morning. Pt took Tylenol but the fever gradually got worse. His fever was so high and pt went to see Dr and Dr prescribed Percocet. Pt's spouse reported to pharmacy on Tuesday afternoon (Pt's fever was still high). On Wednesday 10/18/17, pt's fever went down and he's having little swelling where he got PNEUMOVAX.
your vaccine is injuring people; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (your vaccine is injuring people) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (your vaccine is injuring people). At the time of the report, VACCINATION COMPLICATION (your vaccine is injuring people) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment details not provided.
Day of First shot:  headache, sore arm, extreme exhaustion, feeling that some virus or illness was coming on, intermittent chills. 36 hours after first shot:  sore arm, headache, stomach ache (upper and lower), cramping, swollen gland on front of neck (just one gland).  Had all of these symptoms on my second shot too, but not as bad. I did not have a swollen throat/neck gland, BUT had shortness of breath/asthma reaction on my second shot, and chest & sinus congestion.  The intermittent asthma/shortness of breath, (haven't had in a long time), was without wheezing. I used my albuterol rescue inhalor and it seems to help me get through these boughts. The asthma came on at about 29-36 hrs and has lasted 6 days so far.
After waiting 15 minutes post injection observation period from receiving Pfizer Covid Vaccine Dose #1, patient returned to work space in pharmacy.  Patient began having SOB, dizziness, and unable to stand.  Patient was brought by wheelchair back to Immunizations where patient was redirected to Emergency Department.
Headache, Myalgia, Fever, Rash & NauseaVomiting Narrative:
Child received travel vaccines, within 1 hour had severe hive reaction and severe agitation, change in mental status
PT WAS GIVEN UNDILUTED PEDIATRIC PFIZER INSTEAD OF ADULT PFIZER
This spontaneous report as received from a pharmacist refers to a patient of unknown demographics. No concurrent conditions or medical history were provided. On 06-AUG-2014, the patient was vaccinated with the first dose of RECOMBIVAX HB 10/1.0 microgram/ml injection and, on  22-OCT-2014 (reported as "today"), the patient was coming into the office to receive the second dose of RECOMBIVAX HB (dose, route of administration, indication, lot# and expiry date unspecified for both). No concomitant medications were reported. No adverse symptoms were reported. Additional information has been requested.
Moderna Covid 19 Vaccine EUA Patient complained of having red, raised, warmth, swelling which started the size of nickel and grew to 50c piece. was tender, painful at touch. No fever, & chills, Gi or  headache reported Did take Ibuprofen for the pain
Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 11-MAY-2010, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), at a healthcare facility/office as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 28-DEC-2012, the patient was treated by the healthcare facility/office (by an unspecified healthcare professional) for a persistent and severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The reporter considered the events to be related to ZOSTAVAX. The outcome of the events was unknown.  Additional information has been requested.
After receiving the shot, patient noticed redness to area. After 6 hr she had red rash on the deltoid area. The rash was not itching and resolved 1 day later.
Pt received flu shot 1114 am, reported itching to injection site and redness noted. Wheezing (R) upper anterior lobe EMS notified after epinephrine,  0.3 ml SQ given (R) arm.
This case was reported by a healthcare professional (who was also the vaccination subject), via Merck, and described the occurrence of not responding to therapy in a male subject of unspecified age who was vaccinated with ENGERIX B(GlaxoSmithKline). On an unspecified date, the subject received the 1st dose, 2nd dose and 3rd dose of ENGERIX B (unknown). At an unspecified time after vaccination with ENGERX B, the subject experienced not responding to therapy. The subject reported that he did not seroconvert following a three dose series of ENGERIX B. At the time of reporting, the outcome of the event was unspecified.
Painful; Horrible; Itchy spots on my head; Got the shingles / Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In MAY-2022, several years after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got the shingles / Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). On an unknown date, the patient experienced pain (Verbatim: Painful), feels awful (Verbatim: Horrible) and pruritus (Verbatim: Itchy spots on my head). The outcome of the vaccination failure was unknown and the outcome of the shingles and pruritus were not resolved and the outcome of the pain and feels awful were not reported.   It was unknown if the reporter considered the vaccination failure, shingles, pain, feels awful and pruritus to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, pain, feels awful and pruritus to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 31-MAR-2023 This case was reported by consumer via  interactive digital media. The reporter reported that he or she received Shingles vaccine and experienced shingles. The reporter reported that now they are stated that it was happen because the vaccine was taken many years ago. The reporter reported that it was painful and horrible and he or she still had itchy spot on his or her head. The reporter stated that he or she had to wait for another year for vaccination because he or she had antibodies. The reporter stated that how about the vaccinating the people at the borders as his or her family had too so many years ago.  The follow-up could not be possible as the as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory details were unknown at a time of reporting.
Daughter fainted 20 hours after vaccine.  Was treated by school nurse who observed elevated heart rate (150 bpm).   Eventually heart rate normalized;  took daughter to pediatrician for further evaluation.   Not clear if fainting was related to the vaccine but it has never happened to her before and the timing of the two seems odd.
Student administered first shot as RN and then realized it had no vaccine in it/then administered second shot with actual vaccine in it.  Student was working with  RN who also did not report to floor supervisors or any management staff. Patient was in observation area and saw RN and questioned her about incident. RN then found other RN's and explained what had happened, Patient/son were concerned it had been a dirty needle and or wrong medication,
Patient was mistakenly scheduled for, and received her second dose of the Moderna vaccine series 22 days following her first dose, outside of the recommended 28 days and 4 day grace period per CDC. Attempted to notify patient of mistake, multiple calls made without success. Will continue to try to get in contact with patient. Per CDC, patient does not need to repeat dose or series.
The patient was given 0.5 ml of moderna for the booster dose instead of 0.5 ml. the patients first series was johnson and johnson. the patient has had no adverse reactions.
Feeling cold, shivering at night after the vaccination (we couldn't measure the temperature). Two days after the vaccination: stiff neck and headache, three days after: stiff neck and pain: nearly unable to get in or out the bed due to the stiff neck or doing anything, immense headache and immense neck pain. Pain pills (high dosage ibuprofen) reduced pain but not as long as expected (Patient hasn't taken any painkiller within years before this). Severe stiff neck pain and headache on day four, five and six after the vaccination. Seven days after vaccination: slightly better, less neck pain and headache but still there, still taken Ibuprofen
This spontaneous report as received from a nurse refers to a child patient (reported as less than 2 years of age) of unknown gender. On 17-SEP-2014, the patient was inadvertently vaccinated with PNEUMOVAX23 0.5 ml, intramuscular (lot number and expiration date were not reported) instead of PREVNAR13. No adverse effects were reported. Additional information has been requested.
12/19/20 Covid Pfizer 01/9/2021 Covid Pfizer 8/11/21 ill 8/12/21 + Covid PCR test
Child received Hep B on 12/22/2001. Within 3 hours child had severe headache, raised rash over entire body, swelling of face. Over next 2-3 days child developed nausea and vomiting. Headache and rash continued. Child was taken to ER and was told he had a "strep throat". Given a prescription for PCN which was never given to child.
Severe headaches at 5:30pm that evening I received the shot. I woke up on 6/27 with extreme fatigue, severe muscle weakness, a temp of 101.8. As the day went on, by mid morning, I was also experiencing nauseous, dizziness, and tingling down my legs. My temp last until about 9:30pm with all the other symptoms listed. On 6/28, I woke up with a severe headache and severe muscle weakness in my hands. By 8:30AM, all symptoms had subsided.
Pt received 0.3ml of an adult pfizer vaccine.  The vaccine was mixed with 0.8ml of NaCl instead of 1.8ml of NaCl.
Intermittent chest pains for about 4-5 days. Swelling and pain of the lymph nodes under my arm lasting several months.
41 hours after vaccine, diarrhea, vomiting for approx 12 hours, 49 hours after vaccine began severe hives and itching for about 15 hours
Pt complained of "warm rush feeling" similar to after first dose. No reports of pain or shortness of breath, dizziness, rash, or itchiness. VS monitored, BP initially 196/106, resolved to 137/94 upon recheck. HR 90s- 120 sinus rhythm. PO fluids and supine position for one hour until resolution of symptoms. Discharged and advised to follow up with primary care and allergist as needed. Safety maintained.
left eyelid swollen; she sweat a lot; rash on head around bump on her left; swollen lymph nodes on neck left side/right side/swollen lymph node on collar bone right side; pain in left side of her face; Fever; feel tired; felt like her body was hot; bump on head on left side; face was numb on left side; pimples to left eyebrows; possibly has shingles; This is a spontaneous report from a contactable consumer (patient). A 27 years old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL0140) at her right arm at single dose for COVID-19 immunization on 29Dec2020. Relevant history included she had UTI, acne and dandruff which she had before the vaccine. Concomitant drug included clomifene citrate (CLOMID) since 30Dec2020 (5 days regimen). Past drug included she was taking Ampicillin 25mg prior to vaccine (last dose 2 days before vaccine).  The patient experienced face was numb on left side since 02Jan2021. The patient also experienced  pain in left side of her face, swollen lymph node on neck left side/neck right side, feel tired, felt like her body was hot, bump on head on left side, rash on head around bump on her left and fever since 03Jan2020. She took medication for fever. She felt good when take Motrin or Tylenol and then it came back again being tired. Then, the patient stated she sweat a lot since 04Jan2021, she had swollen lymph node on collar bone right side since 05Jan2021. The had left eyelid swollen since 06Jan2021. The patient also experienced pimples to left eyebrows that started Saturday or Sunday  and possibly had shingles since unknown date in Jan2021. The patient went to the doctor because the doctor suggested that she had shingles and she had the shingles test on 06Jan2021, while she had not gotten the results back yet. The outcome of event Fever was recovered with sequel on 06Jan2021. Outcome of event possibly had shingles was unknown. The outcome of event she sweat a lot was Resolving. The outcome of other events was not resolved.  The events pain in left side of her face, swollen lymph node on neck left side, rash on head around bump on her left, left eyelid swollen and pimples to left eyebrows was worsened.
2nd time having COVID for male 20; tested positive; tested positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 03Aug2022, outcome "recovered" and all described as "tested positive"; DISEASE RECURRENCE (medically significant), outcome "unknown", described as "2nd time having COVID for male 20". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) positive, notes: 2nd time having COVID for male 20; (03Aug2022) Positive, notes: 3 out of 9 of us tested positive.  Clinical Information- Reporter was reporting any issues (side effects, complaints, etc.) with the product. Reported issue occur after use of the product. Event information: Event experienced: Rebounded. Admission to hospital due to the event: No. Still experienced: Fine now. Event experienced: Nasal congestion. Admission to hospital due to the event: No. Still experienced: Fine now. Event experienced: Body aches. Admission to hospital due to the event: No. Still experienced: Fine now. Event experienced: Low grade fever, 99.3. Admission to hospital due to the event: No. Still experienced: Fine now. Event experienced: Low energy. Admission to hospital due to the event: No. Any treatment received: No. Still experienced: Fine now. Event experienced: Foggy mind. Admission to hospital due to the event: No. Any treatment received: No. Still experienced: Fine now. Ritonavir (Paxlovid). Dosage and how often taken (for example, 20 mg once a day, 10 mg twice a day): 10 mg 2x a day. Still taking: No. Other product(s) that were taken together with those indicated above: Yes. Name of additional product: Day/night Nyquill tablets. Dates started: 05Aug2022 stopped 10Aug. Still taking: No Name of additional product: rebound Sat am 13Aug2022. Ibuprophen Day/night Nyquill tablets. Lost taste and smell after rebounding on 16Aug2022 used Flonase and to flush sinuses. Finally tested negative on Saturday 20Aug2022 was attending a small family gathering Friday 30Jul for a week. 3 out of 9 of us tested positive on Wednesday 03Aug. none of the other 6 tested positive. Male 20 fully vaccinated and 1 boosted felt fine after 4 days. Individual female 65 fully vaccinated (Pfizer) and 2 booster (Pfizer) recovered w/o Paxlovid. 2nd time having COVID for male 20 and female 65. Myself (Moderna) vaccinated w/o 1 booster, first time getting COVID. Paxlovid helped but 4 days after completing course COVID rebound and felt worse than when I first tested positive on03Aug.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt stated it started hurting right away and continued to hurt over next 2 days. On the night of the 23rd. Pt began to look red + felt warm. No fever. Pt came into office on 7/24 Dx'd with cellulitis Tx with 500mg Cephalexin BID.
Jynneos was given IM instead of subcutaneously; Case reference number US-BN-2022-004702 is a spontaneous case report initially received on 16-Nov-2022 from pharmacist via Communication (reference number: USBAV22-1962) and concerns an adult male patient.  The patient's medical history and concomitant medication details were not provided.  On 14-Nov-2022, the patient was vaccinated with the first dose of Jynneos vaccine (Smallpox and Monkeypox Vaccine, Live, Nonreplicating; batch number: FDP00016, expiration date 10-Jan-2023), at dose reported as 0,5 mL administered intramuscularly (IM) (explicitly coded as 'inappropriate route of vaccination') at an unknown site, for monkeypox prophylaxis. As reported, Jynneos was given to the patient with a one-inch needle instead of a 5/8 inch, so it was given IM instead of subcutaneously.  At the time of this report, it was unknown if the patient experienced any adverse event due to Jynneos vaccination.  Additional information received from Bavarian Nordic on 16-Nov-2022 included local BN case ID.; Reporter's Comments: An adult male patient born in 1977 was vaccinated with the first dose of Jynneos vaccine, at dose reported as 0,5 mL administered intramuscularly (IM), which is considered as inappropriate route of vaccination, at an unknown site, for monkeypox prophylaxis. Reportedly, at the time of this report, it was unknown if the patient experienced any adverse event due to Jynneos vaccination. The event of incorrect route of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Incorrect route of product administration has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: An adult male patient born in 1977 was vaccinated with the first dose of Jynneos vaccine, at dose reported as 0,5 mL administered intramuscularly (IM), which is considered as inappropriate route of vaccination, at an unknown site, for monkeypox prophylaxis. Reportedly, at the time of this report, it was unknown if the patient experienced any adverse event due to Jynneos vaccination. The event of incorrect route of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Incorrect route of product administration has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Patient reported that several days after injection she developed nausea, diarrhea, dry cough, headache, fever and chills.  She states she was seen at Hospital ER on 1/16/21 and was given fluids for dehydration.  She states she was tested for COVID-19 and was negative.